In the video below, Motley Fool health-care analyst Max Macaluso takes a question from a Fool reader, who asks, "What do you think of AbbVie (ABBV 1.31%)?"


AbbVie has generated a lot of buzz in the pharmaceuticals space ever since it spun off from Abbott Labs. What do we think of it here at the Fool?
In the video below, Motley Fool health-care analyst Max Macaluso takes a question from a Fool reader, who asks, "What do you think of AbbVie (ABBV 1.31%)?"
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.